These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32542057)

  • 1. Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes.
    Ji H; Godsland I; Oliver NS; Hill NE
    PLoS One; 2020; 15(6):e0234319. PubMed ID: 32542057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).
    Kosiborod M; Gomes MB; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Watada H; Shimomura I; Chen H; Cid-Ruzafa J; Fenici P; Hammar N; Surmont F; Tang F; Khunti K;
    Cardiovasc Diabetol; 2018 Nov; 17(1):150. PubMed ID: 30486889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic control and cardiovascular risk factors in type 2 diabetes: a population-based study.
    Bruno G; Cavallo-Perin P; Bargero G; Borra M; D'Errico N; Pagano G
    Diabet Med; 1998 Apr; 15(4):304-7. PubMed ID: 9585395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of red cell distribution width, glycaemic control and diabetes related complications - the ARDENT Study.
    Arif MA; Syed F; Niazi R; Arif SA; Javed MU; Bashir A; Mansoor S
    J Pak Med Assoc; 2019 Apr; 69(4):483-488. PubMed ID: 31000849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients should be evaluated for blood glucose variability?
    Candido R
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():9-12. PubMed ID: 24034514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus.
    Bijelic R; Balaban J; Milicevic S; Sipka SU
    Med Arch; 2020 Feb; 74(1):14-18. PubMed ID: 32317828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of future microvascular and macrovascular disease in people with Type 1 diabetes of very long duration: a national study with 10-year follow-up.
    Adamsson Eryd S; Svensson AM; Franzén S; Eliasson B; Nilsson PM; Gudbjörnsdottir S
    Diabet Med; 2017 Mar; 34(3):411-418. PubMed ID: 27647178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Ganda OP; Arkin CF
    Diabetes Care; 1992 Oct; 15(10):1245-50. PubMed ID: 1425083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic health and vascular complications in type 1 diabetes.
    Bhattarai S; Godsland IF; Misra S; Johnston DG; Oliver N
    J Diabetes Complications; 2019 Sep; 33(9):634-640. PubMed ID: 31248795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of glucose control.
    Edelman SV
    Med Clin North Am; 1998 Jul; 82(4):665-87. PubMed ID: 9706116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort.
    Slieker RC; van der Heijden AAWH; Nijpels G; Elders PJM; 't Hart LM; Beulens JWJ
    Cardiovasc Diabetol; 2019 Dec; 18(1):170. PubMed ID: 31830993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between sociodemographic and clinical characteristics and poor glycaemic control: a longitudinal cohort study.
    McBrien KA; Manns BJ; Hemmelgarn BR; Weaver R; Edwards AL; Ivers N; Rabi D; Lewanczuk R; Braun T; Naugler C; Campbell D; Saad N; Tonelli M
    Diabet Med; 2016 Nov; 33(11):1499-1507. PubMed ID: 26526088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.